0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global C1-INH Replacement Therapy Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-1C18464
Home | Market Reports | Health| Pharmacy
Global C1 INH Replacement Therapy Market Research Report 2024
BUY CHAPTERS

Global C1-INH Replacement Therapy Market Research Report 2026

Code: QYRE-Auto-1C18464
Report
2026-02-10
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

C1-INH Replacement Therapy Market

The global C1-INH Replacement Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
C1-INH replacement therapy is a treatment used to manage hereditary angioedema (HAE) by restoring the deficient or dysfunctional C1 esterase inhibitor (C1-INH) protein in patients.Replacement therapy involves administering C1-INH concentrates (e.g., Berinert, Cinryze, Haegarda), either during acute attacks or as a preventive measure, to normalize C1-INH levels, reducing the frequency and severity of HAE symptoms. It is available in intravenous or subcutaneous forms for flexible administration.
The North American market for C1-INH Replacement Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for C1-INH Replacement Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for C1-INH Replacement Therapy in Acquired Angioedema is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of C1-INH Replacement Therapy include CSL Behring, Takeda, Pharming Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global C1-INH Replacement Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding C1-INH Replacement Therapy. The C1-INH Replacement Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global C1-INH Replacement Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist C1-INH Replacement Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of C1-INH Replacement Therapy Market Report

Report Metric Details
Report Name C1-INH Replacement Therapy Market
Segment by Type
  • Subcutaneous Injection
  • Intravenous Injection
Segment by Application
  • Acquired Angioedema
  • Hereditary Angioedema
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL Behring, Takeda, Pharming Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for C1-INH Replacement Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the C1-INH Replacement Therapy Market report?

Ans: The main players in the C1-INH Replacement Therapy Market are CSL Behring, Takeda, Pharming Healthcare

What are the Application segmentation covered in the C1-INH Replacement Therapy Market report?

Ans: The Applications covered in the C1-INH Replacement Therapy Market report are Acquired Angioedema, Hereditary Angioedema

What are the Type segmentation covered in the C1-INH Replacement Therapy Market report?

Ans: The Types covered in the C1-INH Replacement Therapy Market report are Subcutaneous Injection, Intravenous Injection

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C1-INH Replacement Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Subcutaneous Injection
1.2.3 Intravenous Injection
1.3 Market by Application
1.3.1 Global C1-INH Replacement Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Acquired Angioedema
1.3.3 Hereditary Angioedema
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global C1-INH Replacement Therapy Market Perspective (2021–2032)
2.2 Global C1-INH Replacement Therapy Growth Trends by Region
2.2.1 Global C1-INH Replacement Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 C1-INH Replacement Therapy Historic Market Size by Region (2021–2026)
2.2.3 C1-INH Replacement Therapy Forecasted Market Size by Region (2027–2032)
2.3 C1-INH Replacement Therapy Market Dynamics
2.3.1 C1-INH Replacement Therapy Industry Trends
2.3.2 C1-INH Replacement Therapy Market Drivers
2.3.3 C1-INH Replacement Therapy Market Challenges
2.3.4 C1-INH Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top C1-INH Replacement Therapy Players by Revenue
3.1.1 Global Top C1-INH Replacement Therapy Players by Revenue (2021–2026)
3.1.2 Global C1-INH Replacement Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top C1-INH Replacement Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by C1-INH Replacement Therapy Revenue
3.4 Global C1-INH Replacement Therapy Market Concentration Ratio
3.4.1 Global C1-INH Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C1-INH Replacement Therapy Revenue in 2025
3.5 Global Key Players of C1-INH Replacement Therapy Head Offices and Areas Served
3.6 Global Key Players of C1-INH Replacement Therapy, Products and Applications
3.7 Global Key Players of C1-INH Replacement Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 C1-INH Replacement Therapy Breakdown Data by Type
4.1 Global C1-INH Replacement Therapy Historic Market Size by Type (2021–2026)
4.2 Global C1-INH Replacement Therapy Forecasted Market Size by Type (2027–2032)
5 C1-INH Replacement Therapy Breakdown Data by Application
5.1 Global C1-INH Replacement Therapy Historic Market Size by Application (2021–2026)
5.2 Global C1-INH Replacement Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America C1-INH Replacement Therapy Market Size (2021–2032)
6.2 North America C1-INH Replacement Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America C1-INH Replacement Therapy Market Size by Country (2021–2026)
6.4 North America C1-INH Replacement Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe C1-INH Replacement Therapy Market Size (2021–2032)
7.2 Europe C1-INH Replacement Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe C1-INH Replacement Therapy Market Size by Country (2021–2026)
7.4 Europe C1-INH Replacement Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific C1-INH Replacement Therapy Market Size (2021–2032)
8.2 Asia-Pacific C1-INH Replacement Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific C1-INH Replacement Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific C1-INH Replacement Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America C1-INH Replacement Therapy Market Size (2021–2032)
9.2 Latin America C1-INH Replacement Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America C1-INH Replacement Therapy Market Size by Country (2021–2026)
9.4 Latin America C1-INH Replacement Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa C1-INH Replacement Therapy Market Size (2021–2032)
10.2 Middle East & Africa C1-INH Replacement Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa C1-INH Replacement Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring C1-INH Replacement Therapy Introduction
11.1.4 CSL Behring Revenue in C1-INH Replacement Therapy Business (2021–2026)
11.1.5 CSL Behring Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda C1-INH Replacement Therapy Introduction
11.2.4 Takeda Revenue in C1-INH Replacement Therapy Business (2021–2026)
11.2.5 Takeda Recent Development
11.3 Pharming Healthcare
11.3.1 Pharming Healthcare Company Details
11.3.2 Pharming Healthcare Business Overview
11.3.3 Pharming Healthcare C1-INH Replacement Therapy Introduction
11.3.4 Pharming Healthcare Revenue in C1-INH Replacement Therapy Business (2021–2026)
11.3.5 Pharming Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global C1-INH Replacement Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Subcutaneous Injection
 Table 3. Key Players of Intravenous Injection
 Table 4. Global C1-INH Replacement Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global C1-INH Replacement Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global C1-INH Replacement Therapy Market Size by Region (US$ Million), 2021–2026
 Table 7. Global C1-INH Replacement Therapy Market Share by Region (2021–2026)
 Table 8. Global C1-INH Replacement Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global C1-INH Replacement Therapy Market Share by Region (2027–2032)
 Table 10. C1-INH Replacement Therapy Market Trends
 Table 11. C1-INH Replacement Therapy Market Drivers
 Table 12. C1-INH Replacement Therapy Market Challenges
 Table 13. C1-INH Replacement Therapy Market Restraints
 Table 14. Global C1-INH Replacement Therapy Revenue by Players (US$ Million), 2021–2026
 Table 15. Global C1-INH Replacement Therapy Market Share by Players (2021–2026)
 Table 16. Global Top C1-INH Replacement Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on C1-INH Replacement Therapy Revenue, 2025
 Table 17. Ranking of Global Top C1-INH Replacement Therapy Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by C1-INH Replacement Therapy Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of C1-INH Replacement Therapy, Headquarters and Area Served
 Table 20. Global Key Players of C1-INH Replacement Therapy, Products and Applications
 Table 21. Global Key Players of C1-INH Replacement Therapy, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global C1-INH Replacement Therapy Market Size by Type (US$ Million), 2021–2026
 Table 24. Global C1-INH Replacement Therapy Revenue Market Share by Type (2021–2026)
 Table 25. Global C1-INH Replacement Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global C1-INH Replacement Therapy Revenue Market Share by Type (2027–2032)
 Table 27. Global C1-INH Replacement Therapy Market Size by Application (US$ Million), 2021–2026
 Table 28. Global C1-INH Replacement Therapy Revenue Market Share by Application (2021–2026)
 Table 29. Global C1-INH Replacement Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global C1-INH Replacement Therapy Revenue Market Share by Application (2027–2032)
 Table 31. North America C1-INH Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America C1-INH Replacement Therapy Market Size by Country (US$ Million), 2021–2026
 Table 33. North America C1-INH Replacement Therapy Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe C1-INH Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe C1-INH Replacement Therapy Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe C1-INH Replacement Therapy Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific C1-INH Replacement Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific C1-INH Replacement Therapy Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific C1-INH Replacement Therapy Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America C1-INH Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America C1-INH Replacement Therapy Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America C1-INH Replacement Therapy Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa C1-INH Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa C1-INH Replacement Therapy Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa C1-INH Replacement Therapy Market Size by Country (US$ Million), 2027–2032
 Table 46. CSL Behring Company Details
 Table 47. CSL Behring Business Overview
 Table 48. CSL Behring C1-INH Replacement Therapy Product
 Table 49. CSL Behring Revenue in C1-INH Replacement Therapy Business (US$ Million), 2021–2026
 Table 50. CSL Behring Recent Development
 Table 51. Takeda Company Details
 Table 52. Takeda Business Overview
 Table 53. Takeda C1-INH Replacement Therapy Product
 Table 54. Takeda Revenue in C1-INH Replacement Therapy Business (US$ Million), 2021–2026
 Table 55. Takeda Recent Development
 Table 56. Pharming Healthcare Company Details
 Table 57. Pharming Healthcare Business Overview
 Table 58. Pharming Healthcare C1-INH Replacement Therapy Product
 Table 59. Pharming Healthcare Revenue in C1-INH Replacement Therapy Business (US$ Million), 2021–2026
 Table 60. Pharming Healthcare Recent Development
 Table 61. Research Programs/Design for This Report
 Table 62. Key Data Information from Secondary Sources
 Table 63. Key Data Information from Primary Sources
 Table 64. Authors List of This Report


List of Figures
 Figure 1. C1-INH Replacement Therapy Picture
 Figure 2. Global C1-INH Replacement Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global C1-INH Replacement Therapy Market Share by Type: 2025 vs 2032
 Figure 4. Subcutaneous Injection Features
 Figure 5. Intravenous Injection Features
 Figure 6. Global C1-INH Replacement Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global C1-INH Replacement Therapy Market Share by Application: 2025 vs 2032
 Figure 8. Acquired Angioedema Case Studies
 Figure 9. Hereditary Angioedema Case Studies
 Figure 10. C1-INH Replacement Therapy Report Years Considered
 Figure 11. Global C1-INH Replacement Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global C1-INH Replacement Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global C1-INH Replacement Therapy Market Share by Region: 2025 vs 2032
 Figure 14. Global C1-INH Replacement Therapy Market Share by Players in 2025
 Figure 15. Global C1-INH Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by C1-INH Replacement Therapy Revenue in 2025
 Figure 17. North America C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America C1-INH Replacement Therapy Market Share by Country (2021–2032)
 Figure 19. United States C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe C1-INH Replacement Therapy Market Share by Country (2021–2032)
 Figure 23. Germany C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific C1-INH Replacement Therapy Market Share by Region (2021–2032)
 Figure 31. China C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America C1-INH Replacement Therapy Market Share by Country (2021–2032)
 Figure 39. Mexico C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa C1-INH Replacement Therapy Market Share by Country (2021–2032)
 Figure 43. Israel C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE C1-INH Replacement Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. CSL Behring Revenue Growth Rate in C1-INH Replacement Therapy Business (2021–2026)
 Figure 47. Takeda Revenue Growth Rate in C1-INH Replacement Therapy Business (2021–2026)
 Figure 48. Pharming Healthcare Revenue Growth Rate in C1-INH Replacement Therapy Business (2021–2026)
 Figure 49. Bottom-up and Top-down Approaches for This Report
 Figure 50. Data Triangulation
 Figure 51. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS